•
Jun 30, 2023
AirSculpt Q2 2023 Earnings Report
AirSculpt's financial performance improved in the second quarter of 2023, with revenue and net income increasing compared to the prior year period.
Key Takeaways
AirSculpt Technologies reported a 12.2% increase in revenue to $55.7 million and a net income of $1.8 million for the second quarter of 2023. The company also saw a 13.4% increase in case volume, reflecting strong demand for its minimally invasive body contouring procedures.
Cases increased 13.4% year-over-year to 4,186.
Revenue increased 12.2% year-over-year to $55.7 million.
Net income was $1.8 million, compared to $0.6 million in the prior year period.
Diluted income per share was $0.03, and diluted adjusted net income per share was $0.13.
AirSculpt
AirSculpt
Forward Guidance
The Company projects full year 2023 revenue and adjusted EBITDA guidance as follows and expects to perform at the higher end of both revenue and Adjusted EBITDA ranges:
Positive Outlook
- Revenues in a range of $187 to $192 million
- Adjusted EBITDA in a range of $43 to $45 million
- Adjusted EBITDA to cash flow from operations conversion ratio of approximately 65%
- Five new center openings
- Expects to open one additional center in the third quarter of 2023 bringing the total of new openings to five and achieving the full year target for center openings.
Challenges Ahead
- Pre-opening costs are projected to be approximately $5 million for the full year 2023.
- Failure to open and operate new centers in a timely and cost-effective manner
- Inability to open new centers due to rising interest rates and increased operating expenses due to rising inflation
- Shortages or quality control issues with third-party manufacturers or suppliers
- Competition for surgeons